New drug combo may keep leukemia at bay after transplant
NCT ID NCT03286530
First seen Mar 31, 2026 · Last updated May 17, 2026 · Updated 5 times
Summary
This study tests whether the drug ruxolitinib can lower the chance of leukemia returning after a stem cell transplant in older adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Participants take ruxolitinib as a maintenance therapy after transplant. The goal is to improve survival without causing severe graft-versus-host disease (GVHD).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02115, United States
-
Medical College of Wisconsin
Wauwatosa, Wisconsin, 53226, United States
-
The Ohio State University
Columbus, Ohio, 43210, United States
-
Vanderbilt University
Nashville, Tennessee, 37235, United States
-
Washington University
St Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.